IPP Bureau
Exelixis in-licenses second anti-cancer compound from Aurigene
By IPP Bureau - October 15, 2021
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
AUM Biosciences closes US $ 27 million `Series A’ funding round
By IPP Bureau - October 15, 2021
Everlife leads the series A round, and SPRIM Global Investments participates in the financing syndicate
Expect normal quarter in Q2FY22: Emkay
By IPP Bureau - October 15, 2021
Emkay Research expects Q2FY22 to be a normalised quarter for pharma companies that it tracks. A summary of the report
.jpg "Smith’s Detection confirms BioFlash detects airborne Covid-19")
Smith’s Detection confirms BioFlash detects airborne Covid-19
By IPP Bureau - October 14, 2021
It works by collecting aerosols and identifies the presence of dangerous pathogens using sensitive, specific and rapid detection in near-real time without laboratory analysis
Hospitals to accelerate digital investments: Frost & Sullivan
By IPP Bureau - October 14, 2021
The survey revealed that improving customer experience (CX) and operational efficiencies are top priorities, which healthcare organizations aim to attain by deploying digital health solutions
Sputnik Light has 70 % efficacy against infection with Delta: Gamaleya analysis
By IPP Bureau - October 14, 2021
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
FICCI annual healthcare conference from Oct. 20-22nd 2021
By IPP Bureau - October 14, 2021
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
IOL receives Korean FDA approval
By IPP Bureau - October 14, 2021
The company’s pharmaceutical API products Ibuprofen and fenofibrate got the go-ahead
Supreem Pharma launches its superfoods division
By IPP Bureau - October 13, 2021
It has planned an investment of over Rs 80 crore in the next five years
PCI Pharma Services acquires LSNE for its CDMO business
By IPP Bureau - October 13, 2021
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Roche’s 8-year safety data of Ocrevus shows reduced risk in multiple sclerosis patients
By IPP Bureau - October 13, 2021
New safety data show a consistent benefit-risk profile across all Ocrevus clinical trials
SecureKloud to list subsidiary Healthcare Triangle on Nasdaq
By IPP Bureau - October 13, 2021
The company plans to raise US $ 15 million
Dr Reddy’s launch anti-cancer drug in China
By IPP Bureau - October 13, 2021
Abiraterone by Dr Reddy's becomes the first anti-cancer drug from India to enter the Chinese market
Lonza to expand development services for mammalian products in Singapore
By IPP Bureau - October 13, 2021
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
American Diabetes Association acknowledges Breath Well-being diabetes reversal programme
By IPP Bureau - October 13, 2021
BDMP is a personalised program delivered through the Breathe app to assist people with Type 2 Diabetics to achieve healthy outcomes
